Aurobindo Pharma Limited Capital Reinvestment Ratio
Aurobindo Pharma Limited capital reinvestment ratio. Aurobindo Pharma Limited (AUROPHARMA) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs28.85 Billion) in capital expenditures (Rs13.63 Billion). See Aurobindo Pharma Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aurobindo Pharma Limited (2004–2026)
Capital reinvestment ratio of Aurobindo Pharma Limited from 2004 to 2026. This chart tracks Aurobindo Pharma Limited's Capital Reinvestment Ratio across 22 annual periods. See Aurobindo Pharma Limited (AUROPHARMA) flexibility index to measure the company's free cash flow as a share of total liabilities.
Aurobindo Pharma Limited Capital Reinvestment Ratio by Year (2004–2026)
Aurobindo Pharma Limited capital reinvestment ratio by year from 2004 to 2026. For the full cash flow conversion analysis, see Aurobindo Pharma Limited (AUROPHARMA) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.49x | Rs55.13 Billion | Rs26.86 Billion | ▼ -2.8% |
| 2025 | 0.50x | Rs39.25 Billion | Rs19.68 Billion | ▼ -65.7% |
| 2024 | 1.46x | Rs24.35 Billion | Rs35.62 Billion | ▲ +28.3% |
| 2023 | 1.14x | Rs23.87 Billion | Rs27.20 Billion | ▲ +111.4% |
| 2022 | 0.54x | Rs50.16 Billion | Rs27.05 Billion | ▼ -4.2% |
| 2021 | 0.56x | Rs33.29 Billion | Rs18.74 Billion | ▲ +72.3% |
| 2020 | 0.33x | Rs43.81 Billion | Rs14.31 Billion | ▼ -65.4% |
| 2019 | 0.94x | Rs16.51 Billion | Rs15.59 Billion | ▲ +20.6% |
| 2018 | 0.78x | Rs19.55 Billion | Rs15.30 Billion | ▲ +51.5% |
| 2017 | 0.52x | Rs32.79 Billion | Rs16.94 Billion | ▼ -53.1% |
| 2016 | 1.10x | Rs14.20 Billion | Rs15.66 Billion | ▲ +77.5% |
| 2015 | 0.62x | Rs12.37 Billion | Rs7.68 Billion | ▲ +2.8% |
| 2014 | 0.60x | Rs6.46 Billion | Rs3.90 Billion | ▼ -39.2% |
| 2013 | 0.99x | Rs2.75 Billion | Rs2.73 Billion | ▼ -43.2% |
| 2012 | 1.75x | Rs3.26 Billion | Rs5.71 Billion | ▼ -18.0% |
| 2011 | 2.14x | Rs3.35 Billion | Rs7.16 Billion | ▲ +118.1% |
| 2010 | 0.98x | Rs4.29 Billion | Rs4.20 Billion | ▼ -72.4% |
| 2009 | 3.55x | Rs1.36 Billion | Rs4.83 Billion | ▲ +128.8% |
| 2008 | 1.55x | Rs1.59 Billion | Rs2.46 Billion | ▼ -91.3% |
| 2007 | 17.79x | Rs186.50 Million | Rs3.32 Billion | ▲ +560.9% |
| 2005 | 2.69x | Rs1.22 Billion | Rs3.29 Billion | ▼ -73.3% |
| 2004 | 10.08x | Rs198.90 Million | Rs2.00 Billion | — |